These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 31078573)

  • 21. Comprehensive analysis of "bath salts" purchased from California stores and the internet.
    Schneir A; Ly BT; Casagrande K; Darracq M; Offerman SR; Thornton S; Smollin C; Vohra R; Rangun C; Tomaszewski C; Gerona RR
    Clin Toxicol (Phila); 2014 Aug; 52(7):651-8. PubMed ID: 25089721
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Raising awareness of new psychoactive substances: chemical analysis and in vitro toxicity screening of 'legal high' packages containing synthetic cathinones.
    Araújo AM; Valente MJ; Carvalho M; Dias da Silva D; Gaspar H; Carvalho F; de Lourdes Bastos M; Guedes de Pinho P
    Arch Toxicol; 2015 May; 89(5):757-71. PubMed ID: 24903018
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DARK Classics in Chemical Neuroscience: α-Pyrrolidinovalerophenone ("Flakka").
    Kolesnikova TO; Khatsko SL; Demin KA; Shevyrin VA; Kalueff AV
    ACS Chem Neurosci; 2019 Jan; 10(1):168-174. PubMed ID: 30384587
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The toxicology of bath salts: a review of synthetic cathinones.
    Prosser JM; Nelson LS
    J Med Toxicol; 2012 Mar; 8(1):33-42. PubMed ID: 22108839
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Temporal trends in drug use in Adelaide, South Australia by wastewater analysis.
    Tscharke BJ; Chen C; Gerber JP; White JM
    Sci Total Environ; 2016 Sep; 565():384-391. PubMed ID: 27179320
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of a novel and potentially lethal designer drug (±)-cis-para-methyl-4-methylaminorex (4,4'-DMAR, or 'Serotoni').
    Brandt SD; Baumann MH; Partilla JS; Kavanagh PV; Power JD; Talbot B; Twamley B; Mahony O; O'Brien J; Elliott SP; Archer RP; Patrick J; Singh K; Dempster NM; Cosbey SH
    Drug Test Anal; 2014; 6(7-8):684-95. PubMed ID: 24841869
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Next generation of novel psychoactive substances on the horizon - A complex problem to face.
    Zawilska JB; Andrzejczak D
    Drug Alcohol Depend; 2015 Dec; 157():1-17. PubMed ID: 26482089
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuropharmacological characterization of the new psychoactive substance methoxetamine.
    Hondebrink L; Kasteel EEJ; Tukker AM; Wijnolts FMJ; Verboven AHA; Westerink RHS
    Neuropharmacology; 2017 Sep; 123():1-9. PubMed ID: 28454981
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical toxicology of newer recreational drugs.
    Hill SL; Thomas SH
    Clin Toxicol (Phila); 2011 Oct; 49(8):705-19. PubMed ID: 21970769
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modeling chronic brain exposure to amphetamines using primary rat neuronal cortical cultures.
    Nogueira TB; da Costa Araújo S; Carvalho F; Pereira FC; Fernandes E; Bastos ML; Costa VM; Capela JP
    Neuroscience; 2014 Sep; 277():417-34. PubMed ID: 25047998
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Designer drugs: a medicinal chemistry perspective (II).
    Carroll FI; Lewin AH; Mascarella SW; Seltzman HH; Reddy PA
    Ann N Y Acad Sci; 2021 Apr; 1489(1):48-77. PubMed ID: 32396701
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multi-drug cocktails: Impurities in commonly used illicit drugs seized by police in Queensland, Australia.
    Peck Y; Clough AR; Culshaw PN; Liddell MJ
    Drug Alcohol Depend; 2019 Aug; 201():49-57. PubMed ID: 31181437
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The pharmacology and neurotoxicology of synthetic cathinones.
    Angoa-Perez M; Kuhn DM
    Adv Pharmacol; 2024; 99():61-82. PubMed ID: 38467489
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Designer drugs: mechanism of action and adverse effects.
    Luethi D; Liechti ME
    Arch Toxicol; 2020 Apr; 94(4):1085-1133. PubMed ID: 32249347
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular and clinical aspects of potential neurotoxicity induced by new psychoactive stimulants and psychedelics.
    Rudin D; Liechti ME; Luethi D
    Exp Neurol; 2021 Sep; 343():113778. PubMed ID: 34090893
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New psychoactive substances in substantive evidence in expert practice of the Department of Forensic Medicine, UJCM in the years 2010-2015.
    Maciów-Głąb M; Kula K; Kłys M; Rojek SD
    Arch Med Sadowej Kryminol; 2017; 67(3):178-200. PubMed ID: 29460609
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Presentations due to acute toxicity of psychoactive substances in an urban emergency department in Switzerland: a case series.
    Liakoni E; Dolder PC; Rentsch KM; Liechti ME
    BMC Pharmacol Toxicol; 2016 May; 17(1):25. PubMed ID: 27228985
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human Neuronal Cell Lines as An In Vitro Toxicological Tool for the Evaluation of Novel Psychoactive Substances.
    Sogos V; Caria P; Porcedda C; Mostallino R; Piras F; Miliano C; De Luca MA; Castelli MP
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34202634
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characteristics and circumstances of death related to new psychoactive stimulants and hallucinogens in Australia.
    Darke S; Duflou J; Peacock A; Farrell M; Lappin J
    Drug Alcohol Depend; 2019 Nov; 204():107556. PubMed ID: 31546120
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A 3-year review of new psychoactive substances in casework.
    Elliott S; Evans J
    Forensic Sci Int; 2014 Oct; 243():55-60. PubMed ID: 24810679
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.